Skip to content

Bourda

Active
Private limited company·Detailhandel in farmaceutische producten· 4 yrs active
Fritz De Beulestraat 17 ·9000 Gent, Belgium
KBO/BCE: BE 0772.889.961
Watch Print / PDF
Age4 yrs
Board2
Real estate2 parcels · 1,165 m²

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Bourda is 1.6% (moderate). The 2025 annual accounts show equity of €40k and a net result of €65k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 88% of 1408 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

2 signals · with evidence
Strong solvency vs sector
Solvency is in the sector's strongest quartile: better than 88% of 1408 peers (2025). A comfortable equity buffer.
View the sector comparison
Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-04-2026, 101 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 21-04-2026 101 d early 2026-00083899
31-12-2024 31-07-2025 18-06-2025 43 d early 2025-00154859
31-12-2023 31-07-2024 24-06-2024 37 d early 2024-00160235
31-12-2022 31-07-2023 14-06-2023 47 d early 2023-00130012

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
1.6% Moderate
0%0,5%1,5%4%10%≥25%
Young company +Higher-failure-rate sector +Annual accounts: healthy financial profile −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€65k+1499.3%
Working capital€29k

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 21-04-2026 with the NBB · fiscal year 2025 · micro
€-50k€0€50k€100kOperating result 2022: €-31k€-31kNet result 2022: €-33k€-33kOperating result 2023: €-151€-151Net result 2023: €-867€-867Operating result 2024: €5k€5kNet result 2024: €4k€4kOperating result 2025: €82k€82kNet result 2025: €65k€65k2022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
volatile Too volatile to project: the yearly deviation from the trend is ~41% of the level (threshold 35%). We therefore deliberately show no projection line.
€-40k€-20k€0€20k€40k2022: €-28k2023: €-29k2024: €-25k2025: €40k2022202320242025
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 47, Retail trade · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 77.5% 23.8%
better than 88% of 1408 sector peers
Net result €65k €8k
better than 90% of 1405 sector peers
Equity €40k €26k
better than 58% of 1409 sector peers
Gross operating margin €89k €36k
better than 73% of 1402 sector peers
Total assets €51k €133k
better than 25% of 1409 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P88
2022: P10 · n=42902023: P10 · n=57142024: P10 · n=66982025: P88 · n=14082022 2025
Improving position over 2022-2025 · n=1408-6698
Net result P90
2022: P8 · n=42772023: P35 · n=56942024: P50 · n=66782025: P90 · n=14052022 2025
Improving position over 2022-2025 · n=1405-6678
Equity P58
2022: P10 · n=42982023: P10 · n=57212024: P12 · n=67122025: P58 · n=14092022 2025
Improving position over 2022-2025 · n=1409-6712
Gross operating margin P73
2022: P5 · n=42672023: P34 · n=56682024: P38 · n=66572025: P73 · n=14022022 2025
Improving position over 2022-2025 · n=1402-6657
Describes the position versus peers, not a forecast.
EBITDA
€88k
+669.6% 22-25
Net profit
€65k
+1499.3% 22-25
Cash flow
€71k
+552.1% 22-25
Total assets
€51k
+71.1% 22-25
Equity
€40k
- 22-25
Working capital
€29k
- 22-25
Income taxes
€17k
- 22-25
Debt
€12k
-79.0% 22-25
Debt ≤ 1y
€12k
-69.1% 22-25
Debt > 1y
€18k
-41.3% 22-25
Current ratio
3.54
+741.1% 22-25
Quick ratio
3.44
+858.9% 22-25
Solvency
77.5%
- 22-25
Debt / equity
0.29
- 22-25
ROE
163.0%
- 22-25
ROA
126.3%
+834.5% 22-25
Interest coverage
164.68
+712.3% 22-25
Figures by fiscal year
Fiscal year2025
Depositmicro
Revenue-
EBITDA€88k
Net profit€65k
Cash flow€71k
Staff costs-
Income taxes€17k
Dividends-
Total assets€51k
Equity€40k
Debt€12k
of which ≤ 1y€12k
of which > 1y-
Working capital€29k
Employees (FTE)-
Ratios (computed)
2025
Current ratio3.54
Quick ratio3.44
Working capital ratio57.3%
Solvency77.5%
Debt / equity0.29
Long-term debt ratio-
Interest coverage164.68
Gross margin-
Net margin-
ROA126.3%
ROE163.0%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€51k
Fixed assets 21/28€10k
Intangible fixed assets 21€8k
Tangible fixed assets 22/27€2k
Current assets 29/58€41k
Stocks & contracts in progress 3€1k
Amounts receivable within one year 40/41€15k
Cash & bank 54/58€25k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€51k
Equity 10/15€40k
Contributions / capital 10/11€5k
Reserves 13€34k
Accumulated profits (losses) 14€751
Amounts payable 17/49€12k
Amounts payable within one year 42/48€12k
Income statement
Gross operating margin 9900€89k
Operating result 9901€82k
Financial charges 65€537
Result before taxes 9903€81k
Income taxes 67/77€17k
Net result for the period 9904€65k
Result to be appropriated 9905€65k
You're seeing the latest fiscal year only. Unlock 3 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
100 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Directors

Directors & mandates

2 directors
Current directors & mandates
  • BOURDA Cedric
    Director
    State Gazette act 22362390 (04-10-2022)
    Current
    04-10-2022 → present
  • DE MEYER Tom
    Director
    State Gazette act 22362390 (04-10-2022)
    Current
    04-10-2022 → present
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.

Statutory auditor

1 auditor
Statutory auditor IRE/IBR number Tenure
RSM Interaudit BVCurrent
Company auditor · represented by Inge Saeys
 - 20-09-2022 → present
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Detailhandel in farmaceutische producten(47730)
Legal form Private limited company(610)
Incorporation26-08-2021
StatusActive
Postal code9000

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Fritz De Beulestraat 179000 Gent

Establishment units

1 location
Sanaselect
Steenweg 203, 9473 DenderleeuwVervaardiging van gedistilleerde dranken door distilleren, rectificeren en mengen
since 20212.320.774.488
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area1,165 m²
Buildings2
Building footprint446 m²
Volume (LiDAR)1,031 m³
Tallest building9.5 m · ±1 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
41076B0556/00F000 Flanders 1,021 m² 1 · 346 m² 9.5 m · 1 fl.
44808H0476/00W002 Flanders 144 m² 1 · 101 m² 6.4 m
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

3 acts
Address history · 1
15-04-2026
Seat change: 9000 Gent, Fritz De Beulestraat 17
All acts · 3 updated 4 months ago
2026
15-04-2026 Act object · Notarial deed · General meeting · Name change Open-capture extraction·Julie Declercq
  • Act object: BENAMING, MAATSCHAPPELIJKE ZETEL, ONTSLAGEN, BENOEMINGEN · CenT
  • Notarial deed: 2026-03-30 · CenT
  • General meeting: 2026-03-30 · CenT
  • Name change: Bourda · CenT
  • Purpose change: De vergadering beslist de bestaande tekst van artikel 3 van de statuten, zijnde het voorwerp van de Vennootschap, integraal te vervangen zoals voorzien in het verslag van het bestuursorgaan op datum van 30 maart 2026. · CenT
  • Seat change: 9000 Gent, Fritz De Beulestraat 17 · CenT
  • Officer resignation: 2026-03-30 · De Meyer Tom
  • Officer discharge: 2026-03-30 · De Meyer Tom
  • Statute amendment: 2026-03-30 · CenT
  • Power of attorney: bijzondere volmacht ... om ... alle nuttige of noodzakelijke formaliteiten te vervullen ... en tot het afsluiten van alle overeenkomsten en akkoorden ... om in naam van de vennootschap alle documenten te ondertekenen. · Het Accountantskantoor, Soenen & Grammens
  • Filing: 2026-04-13 · CenT
  • Publication: 2026-04-15 · CenT
Summary: Act object · Notarial deed · General meeting · Name changeNotary: Julie Declercq
2022
04-10-2022 2 directors appointed Director changes
  • DE MEYER Tom, Bestuurder
  • BOURDA Cedric, Bestuurder
Summary: v3.2
2021
30-08-2021 Incorporation of a new VZW Incorporation
Summary: oprichting

Analysis

Snowflake analysis

financial profile on 5 axes
Health100Profitability100Solvency100Growth78Stability94
94 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 100
Profitability 100
Solvency 100
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector
We hold annual accounts for 496 of the 5,225 companies in this sector. 385 of them are within a factor 10 of this company's equity.

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Apotheken47730Detailhandel in farmaceutische producten47730Vervaardiging van gedistilleerde dranken door distilleren, rectificeren en mengen11010Vervaardiging van gedistilleerde dranken door distilleren, rectificeren en mengen11010Handelsbemiddeling in goederen, algemeen assortiment46190Handelsbemiddeling in de niet-gespecialiseerde groothandel46190Groothandel in parfumerieën en cosmetica46450Groothandel in parfumerieën en cosmetica46450Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels47740Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen47741Detailhandel in cosmetica en toiletartikelen in gespecialiseerde winkels47750Detailhandel in cosmetica en toiletartikelen47750
Primary activity highlighted.
Names & trade names
Legal nameNL Bourda
Legal nameNL CenT
Registered office
Fritz De Beulestraat 17
9000 Gent, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.